Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| GLOBAL GEOPH | GGS | 7.79% |
| STAAR SURGIC | STAA | 6.23% |
| KAPSTONE PAP | KS | 6.14% |
| HORNBECK OFF | HOS | 5.99% |
| ANIKA THERAP | ANIK | 5.55% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
We are downgrading Sunoco Inc. (SUN) shares to Underperform from Neutral, reflecting the bearish refining margin outlook.
Weak demand for refined products in the global downturn and increased capacity has squeezed margins throughout the industry. Rising crude oil prices have added to Sunoco’s miseries by increasing the cost of production. With utilization rates remaining at historically low levels, we see a fairly unfavorable macro backdrop for independent refiners over the coming 6- 12 months. Sunoco’s lack of geographic diversification and refining flexibility has also become a major liability, in our view.
Sunoco has announced certain strategic actions to improve the company’s performance and competitiveness in a cost-effective manner. These include the closure of the previously-idled Eagle Point (New Jersey) refinery, a definitive agreement to sell the polypropylene business and cutting its dividend. Early last year, the company sold its Tulsa refinery and Retail Home Heating Oil business.
These liquidity enhancements (expected to save more than $300 annually) will ensure Sunoco’s survival during the downturn, but until there is a more visible refining margin improvement trend, we little reason for investors to own the stock. As has been the case during the last few quarters, non-refining profits are likely to be dwarfed by losses in the main (refining) business.
Given these headwinds, we expect Sunoco shares to be under pressure in the near future. Philadelphia, Pennsylvania-based Sunoco is a leading independent refiner and marketer of petroleum products. The company is also a major chemicals manufacturer and has interests in logistics and cokemaking facilities. Its operations include three refineries having a combined capacity of 675,000 barrels per day.